Natixis Raises Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Natixis boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 695,250 shares of the company's stock after acquiring an additional 31,940 shares during the period. Natixis owned 0.56% of Henry Schein worth $48,111,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Versant Capital Management Inc increased its holdings in shares of Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC grew its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after acquiring an additional 143 shares in the last quarter. Finally, City State Bank purchased a new position in Henry Schein in the 4th quarter worth approximately $55,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Price Performance

Henry Schein stock traded up $0.57 during mid-day trading on Thursday, hitting $66.06. The stock had a trading volume of 238,834 shares, compared to its average volume of 1,609,436. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.09 billion, a P/E ratio of 27.15, a P/E/G ratio of 2.13 and a beta of 0.84. The firm's 50 day moving average is $69.66 and its 200 day moving average is $71.83.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the prior year, the business posted $0.66 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of research analyst reports. StockNews.com downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and increased their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.